| Name: | Clarithromycin EP Impurity Q |
| Catalogue No. | VL740013 |
| CAS No. | 118074-07-0 |
| Molecular Formula | C38H69NO14 |
| Molecular Weight | 763.95 |
| Status | In-stock |
| IUPAC Name | 6-O-Methyl Erythromycin N-Oxide ; |
| Synonyms | Clarithromycin N-Oxide |
| Appearance | In-stock |
| Description | Clarithromycin EP Impurity Q (CAS No: 118074-07-0) or Clarithromycin N-Oxide is a metabolite of Clarithromycin. The clinical efficacy of clarithromycin has been confirmed in the treatment of infections of the lower and upper respiratory tracts, skin, or soft tissues and pediatrics. |
| References | Peters, David H., and Stephen P. Clissold. “Clarithromycin.” Drugs, vol. 44, no. 1, July 1992, pp. 117–64, https://doi.org/10.2165/00003495-199244010-00009. S Ohmori, et al. “Effects of Clarithromycin and Its Metabolites on the Mixed Function Oxidase System in Hepatic Microsomes of Rats.” Drug Metabolism and Disposition, vol. 21, no. 2, American Society for Pharmacology and Experimental Therapeutics, Mar. 1993, pp. 358–63, dmd.aspetjournals.org/content/21/2/358.short. |
